Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia
Authors
Keywords
-
Journal
Journal of Translational Medicine
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-11
DOI
10.1186/s12967-019-2112-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarkers in Pneumonia—Beyond Procalcitonin
- (2019) Meropi Karakioulaki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phospholipid levels in blood during community-acquired pneumonia
- (2019) Daniel C. Müller et al. PLoS One
- Characterization of Bulk Phosphatidylcholine Compositions in Human Plasma Using Side-Chain Resolving Lipidomics
- (2019) Jan D. Quell et al. Metabolites
- Sphingolipids as targets for inhalation treatment of cystic fibrosis
- (2018) Katrin Anne Becker et al. ADVANCED DRUG DELIVERY REVIEWS
- The human metabolic profile reflects macro- and micronutrient intake distinctly according to fasting time
- (2018) A. Sedlmeier et al. Scientific Reports
- Increased Plasma Acetylcarnitine in Sepsis Is Associated With Multiple Organ Dysfunction and Mortality
- (2018) Kuei-Pin Chung et al. CRITICAL CARE MEDICINE
- Sphingolipid pathway enzymes modulate cell fate and immune responses
- (2017) S Molino et al. Immunotherapy
- Macrophages and Phospholipases at the Intersection between Inflammation and the Pathogenesis of HIV-1 Infection
- (2017) Francesca Spadaro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Acid sphingomyelinase mediates human CD4+ T-cell signaling: potential roles in T-cell responses and diseases
- (2017) Aiping Bai et al. Cell Death & Disease
- Acid Sphingomyelinase Inhibition Prevents Development of Sepsis Sequelae in the Murine Liver
- (2017) Ha-Yeun Chung et al. Scientific Reports
- Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics
- (2017) Feng Yan et al. BMC Pulmonary Medicine
- The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age
- (2017) Séverine Trabado et al. PLoS One
- Ferroptosis: process and function
- (2016) Y Xie et al. CELL DEATH AND DIFFERENTIATION
- Lipid metabolites as potential diagnostic and prognostic biomarkers for acute community acquired pneumonia
- (2016) Kelvin K.W. To et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- The regulation of inflammation by oxidized phospholipids
- (2016) Stefan Freigang EUROPEAN JOURNAL OF IMMUNOLOGY
- Transcriptomic Biomarkers for Tuberculosis: Evaluation of DOCK9. EPHA4, and NPC2 mRNA Expression in Peripheral Blood
- (2016) Leonardo S. de Araujo et al. Frontiers in Microbiology
- Plasma Sphingolipids Associated with Chronic Obstructive Pulmonary Disease Phenotypes
- (2015) Russell P. Bowler et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Autophagy in the light of sphingolipid metabolism
- (2015) Eva Bang Harvald et al. APOPTOSIS
- Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsis
- (2015) Huiming Peng et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Role of Sphingolipids in the Pathobiology of Lung Inflammation
- (2015) Riccardo Ghidoni et al. MEDIATORS OF INFLAMMATION
- Lysophosphatidylcholine as a prognostic marker in community-acquired pneumonia requiring hospitalization: a pilot study
- (2014) W. H. Cho et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Community-Acquired Pneumonia
- (2014) Daniel M. Musher et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration—from cell and animal models to human disorders
- (2013) Makoto Taniguchi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Metabolomics in Epidemiology: Sources of Variability in Metabolite Measurements and Implications
- (2013) J. N. Sampson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Incidence of Community-Acquired Lower Respiratory Tract Infections and Pneumonia among Older Adults in the United Kingdom: A Population-Based Study
- (2013) Elizabeth R. C. Millett et al. PLoS One
- Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers
- (2013) Chloe I. Bloom et al. PLoS One
- Inhibition of sphingosine kinase 1 enhances cytotoxicity, ceramide levels and ROS formation in liver cancer cells treated with selenite
- (2012) V. Chatzakos et al. BIOCHEMICAL PHARMACOLOGY
- Phospholipids: “Greasing the wheels” of humoral immunity
- (2012) Joseph W. Brewer BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Biomarkers in community-acquired pneumonia
- (2012) Stefan Krüger et al. Expert Review of Respiratory Medicine
- Prostaglandins and Inflammation
- (2011) Emanuela Ricciotti et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Many Ceramides
- (2011) Yusuf A. Hannun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular Mechanisms of Natural Killer Cell Activation
- (2011) Yenan T. Bryceson et al. Journal of Innate Immunity
- The Human Plasma Lipidome
- (2011) Oswald Quehenberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acid Sphingomyelinase Inhibitors Normalize Pulmonary Ceramide and Inflammation in Cystic Fibrosis
- (2009) Katrin Anne Becker et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Molecular mechanism underlying the suppression of lipid oxidation during endotoxemia
- (2009) Urmila Maitra et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More